Key result
Review summarizes the diagnosis, management, and prognosis of concomitant valvular heart disease and cardiac amyloidosis.
Why the study?
Despite growing interest in cardiac amyloidosis co-existing with valvular heart disease, data beyond aortic stenosis—particularly for mitral and tricuspid regurgitation—remain scarce.
Design
Review article
Authors
Loading...
Encourages amyloid evaluation in aortic stenosis; leaves open optimal management of coexistent mitral/tricuspid regurgitation.
This review summarizes current evidence on the epidemiology, diagnosis, management, and prognosis of concomitant cardiac amyloidosis and valvular heart disease.
Duca et al. (2023) conducted a review in Cardiac amyloidosis and valvular heart disease. This review summarizes the current evidence on the epidemiology, diagnosis, screening, therapeutic management, and prognostic implications of concomitant valvular heart disease and cardiac amyloidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: